DFDA

Hearing Aids (for individuals with hearing loss)

Treatment for Tinnitus

Typical Dosage: Daily use during waking hours

Effectiveness
75%
Safety Score
95%
Clinical Trials
1
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Daily use during waking hours
Time to Effect
Immediate (amplification), weeks (adaptation)
Treatment Duration
Lifetime (as long as hearing loss persists)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$200
Side Effect Mgmt:$0
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$25,000/QALY
QALYs Gained
0.07
Outcome-Based Costs
Cost per Responder
$1,429
Cost per Remission
$10,000
Hearing Aids (for individuals with hearing loss) Outcomes

for Tinnitus

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Remission Rate
+10%
Common Side Effects
Ear irritation/discomfort
+8%
Feedback/occlusion effect
+7%
Initial adjustment period
+15%

Sources:

asha.org
rsdjournal.org
medrxiv.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Hearing Aids (for individuals with hearing loss) in Tinnitus

Notched Noise Therapy for Suppression of Tinnitus

NCT04661995RECRUITINGNA
View Study
108 participants
INTERVENTIONAL
Durham, United States
Started: Mar 1, 2023